ABOUT DIAMYD MEDICAL
ABOUT DIAMYD MEDICAL
The Diamyd Story
CEO Comments
Board & Management
Scientific advisory board
Corporate Governance
Annual General Meeting
Board & Management
Auditors
Articles of Incorporation
Remuneration Principles
Incentive Programs
Partnering
Contact Us
DIABETES
DIABETES
Type 1
LADA
Type 2
Complications
PRODUCTS & PIPELINE
PRODUCTS & PIPELINE
GAD platform
Diamyd
®
Diamyd
®
in Type 1
Diamyd
®
in LADA
Order GAD for research
CLINICAL TRIALS
CLINICAL TRIALS
Clinical development
Diabetes Clinical Trials
Drug Development
INVESTOR RELATIONS
INVESTOR RELATIONS
Press Releases
Financial Reports
Calendar
Owners
Share Trading
Insider Trading
Company Description
PRESS ROOM
PRESS ROOM
Press Releases
News & Mediawatch
Scientific publications
Webcasts/Podcasts
Newsletter Subscription
Media Contact
Home
»
Press Room
»
Scientific Publications
Scientific Publications
Scientific publications on subjects and technologies related to Diamyd Medical.
Sort order
February 2012
GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus (link to article in New England Journal of Medicine – NEJM).
June 2011
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial”. (Link to article in The Lancet)
April 2011
Gene therapy for pain: Results of a phase I clinical trial (Link to article in Annals of Neurology)
November 2010
Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial (Link to article in Diabetologia)
May 2009
GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes (Link to article in Diabetologia)
October 2008
GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes
(Link to article in New England Journal of Medicine - NEJM)
June 2006
Beta cell function and metabolic control during two years of follow-up after GAD65 dose-escalation immunomodulation in adult-onset autoimmune diabetes
June 2005
GAD in metabolic & neurologic disease, June 2005
June 2003
GAD in metabolic & neurologic disease, June 2003
June 2003
A Phase II Clinical Trial Involving Alum-Formulated GAD65 Vaccination of GAD65-Autoantibody Positive Adult Diabetes Patients
Press Room
Press Releases
News & Mediawatch
Scientific publications
Webcasts/Podcasts
Newsletter Subscription
Media Contact